Earnings History Data for Standard BioTools Inc. (LAB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Standard BioTools Inc.
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-10-2024 | AH | LAB | Standard BioTools Inc. | 630.96 | -0.06 | -0.11 | -0.19 | Standard BioTools GAAP EPS of -$0.07 beats by $0.03, revenue of $44.96M beats by $3.96M [10/30/2024 4:59 PM] |
1.96 | 0.08 (3.99%) |
1.96 | 0.08 (4.26%) |
1.21 - 3.04 | 4,215,347 | 2,040,000 | 7,034 | ||
|
||||||||||||||||||
| 31-07-2024 | AH | LAB | Standard BioTools Inc. | 833.60 | -0.09 | -0.10 | -0.18 | Standard BioTools GAAP EPS of -$0.12 misses by $0.03, revenue of $37.2M misses by $11.03M [7/31/2024 4:05 PM] |
1.43 | -0.82 (-36.38%) |
1.63 | -0.61 (-27.23%) |
1.21 - 3.16 | 11,218,551 | 1,970,000 | 8,218 | ||
| 08-05-2024 | AH | LAB | Standard BioTools Inc. | 948.50 | -0.26 | -0.13 | -0.14 | Standard BioTools GAAP EPS of -$0.27 misses by $0.15, revenue of $45.54M misses by $0.46M [5/8/2024 4:37 PM] |
2.42 | 0.18 (8.04%) |
2.23 | -0.01 (-0.45%) |
1.57 - 3.16 | 3,218,817 | 2,550,000 | 5,332 | ||
| 28-02-2024 | AH | LAB | Standard BioTools Inc. | 194.52 | -0.12 | 0.00 | -0.21 | Standard BioTools GAAP EPS of -$0.25 misses by $0.01, revenue of $28.19M beats by $3.29M [2/28/2024 4:31 PM] |
2.25 | -0.12 (-4.85%) |
2.37 | 0.0 (0.00%) |
1.46 - 3.16 | 1,565,360 | 1,350,000 | 36,590 | ||
| 07-11-2023 | AH | LAB | Standard BioTools Inc. | 165.04 | -0.19 | 0.00 | -0.32 | Standard BioTools GAAP EPS of -$0.27 misses by $0.04, revenue of $25.36M beats by $1.76M [11/7/2023 4:43 PM] |
1.89 | -0.10 (-5.28%) |
1.99 | 0.0 (0.00%) |
0.92 - 3.16 | 929,316 | 370,000 | 1,282 | ||
| 08-08-2023 | AH | LAB | Standard BioTools Inc. | 199.10 | -0.18 | 0.00 | -0.39 | Standard BioTools GAAP EPS of -$0.22 misses by $0.01, revenue of $27.67M beats by $3.47M [8/8/2023 4:58 PM] |
2.55 | 0.17 (7.14%) |
0.0 | 0.0 (0.00%) |
0.92 - 2.65 | 223,322 | 110,000 | 0 | ||
| 09-05-2023 | AH | 6:00 PM ET (May 9) |
LAB | Standard BioTools Inc. | 128.08 | -0.14 | 0.00 | -0.31 | Standard BioTools Non-GAAP EPS of -$0.11, revenue of $25.12M [5/9/2023 5:58 PM] |
1.80 | 0.21 (12.85%) |
0.0 | 0.0 (0.00%) |
0.92 - 2.69 | 275,736 | 200,000 | 0 | |
| 14-02-2023 | AH | 6:00 PM ET (Feb 14) |
LAB | Standard BioTools Inc. | 162.56 | -0.21 | 0.00 | -0.06 | Standard BioTools Non-GAAP EPS of -$0.19, revenue of $27.02M [2/14/2023 4:52 PM] |
2.12 | 0.05 (2.42%) |
2.10 | 0.0 (0.00%) |
0.92 - 4.23 | 365,469 | 200,000 | 268 | |
| 08-11-2022 | AH | 6:00 PM ET (Nov 8) |
LAB | Standard BioTools Inc. | 89.67 | -0.32 | 0.00 | -0.13 | Standard BioTools Non-GAAP EPS of -$0.26, revenue of $25.65M [11/8/2022 4:52 PM] |
0.9330 | -0.05 (-4.83%) |
0.98 | 0.0 (0.00%) |
0.92 - 5.09 | 429,623 | 200,000 | 598 | |
|
||||||||||||||||||
| 08-08-2022 | AH | 6:00 PM ET (Aug 8) |
LAB | Standard BioTools Inc. | 113.56 | -0.39 | 0.00 | -0.17 | Standard BioTools Non-GAAP EPS of -$0.33, revenue of $18.78M [8/8/2022 4:48 PM] |
1.71 | -0.33 (-16.42%) |
1.99 | -0.05 (-2.45%) |
1.28 - 7.31 | 1,368,265 | 570,000 | 139 | |
| 05-05-2022 | AH | 6:00 PM ET (May 5) |
LAB | Standard BioTools Inc. | 219.24 | -0.31 | 0.00 | -0.20 | Standard BioTools Non-GAAP EPS of -$0.25 misses by $0.07, revenue of $26.5M beats by $0.85M [5/5/2022 5:22 PM] |
2.88 | -0.12 (-4.15%) |
2.99 | -0.02 (-0.66%) |
2.35 - 7.51 | 745,400 | 730,000 | 2,779 | |